Ullrich Wüllner
Ullrich Wüllner
Klinik für Neurologie, UKB und DZNE Bonn
Verified email at - Homepage
Cited by
Cited by
PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease
B Zheng, Z Liao, JJ Locascio, KA Lesniak, SS Roderick, ML Watt, ...
Science translational medicine 2 (52), 52ra73-52ra73, 2010
Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans
N Striepens, KM Kendrick, V Hanking, R Landgraf, U Wüllner, W Maier, ...
Scientific reports 3 (1), 1-5, 2013
Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains
A Jowaed, I Schmitt, O Kaut, U Wüllner
Journal of Neuroscience 30 (18), 6355-6359, 2010
Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients
JR Bedarf, F Hildebrand, LP Coelho, S Sunagawa, M Bahram, F Goeser, ...
Genome medicine 9 (1), 1-13, 2017
Excitation-induced ataxin-3 aggregation in neurons from patients with Machado–Joseph disease
P Koch, P Breuer, M Peitz, J Jungverdorben, J Kesavan, D Poppe, J Doerr, ...
Nature 480 (7378), 543-546, 2011
Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease
S Paus, HM Brecht, J Köster, G Seeger, T Klockgether, U Wüllner
Movement Disorders 18 (6), 659-667, 2003
SNCA variants are associated with increased risk for multiple system atrophy
SW Scholz, H Houlden, C Schulte, M Sharma, A Li, D Berg, A Melchers, ...
Annals of Neurology: Official Journal of the American Neurological …, 2009
Multiple regions of α‐synuclein are associated with Parkinson's disease
JC Mueller, J Fuchs, A Hofer, A Zimprich, P Lichtner, T Illig, D Berg, ...
Annals of neurology 57 (4), 535-541, 2005
Induction of nitric oxide synthase and nitric oxide‐mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor‐α/lipopolysaccharide
MT Heneka, PA Löschmann, M Gleichmann, M Weller, JB Schulz, ...
Journal of neurochemistry 71 (1), 88-94, 1998
Glutathione depletion and neuronal cell death: the role of reactive oxygen intermediates and mitochondrial function
U Wüllner, J Seyfried, P Groscurth, S Beinroth, S Winter, M Gleichmann, ...
Brain research 826 (1), 53-62, 1999
Mutations in COQ2 in Familial and Sporadic Multiple-System Atrophy
Multiple-System Atrophy Research Collaboration
New England Journal of Medicine 369 (3), 233-244, 2013
Extracellular phosphorylation of the amyloid β‐peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease
S Kumar, N Rezaei‐Ghaleh, D Terwel, DR Thal, M Richard, M Hoch, ...
The EMBO journal 30 (11), 2255-2265, 2011
Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide …
MT Heneka, DL Feinstein, E Galea, M Gleichmann, U Wüllner, ...
Journal of neuroimmunology 100 (1-2), 156-168, 1999
Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones.
U Wüllner, PA Löschmann, JB Schulz, A Schmid, R Dringen, F Eblen, ...
Neuroreport 7 (4), 921-923, 1996
Qigong exercise for the symptoms of Parkinson's disease: a randomized, controlled pilot study
T Schmitz‐Hübsch, D Pyfer, K Kielwein, R Fimmers, T Klockgether, ...
Movement disorders: official journal of the Movement Disorder Society 21 (4 …, 2006
An arginine/lysine‐rich motif is crucial for VCP/p97‐mediated modulation of ataxin‐3 fibrillogenesis
A Boeddrich, S Gaumer, A Haacke, N Tzvetkov, M Albrecht, BO Evert, ...
The EMBO journal 25 (7), 1547-1558, 2006
Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination
I Schmitt, M Linden, H Khazneh, BO Evert, P Breuer, T Klockgether, ...
Biochemical and biophysical research communications 362 (3), 734-739, 2007
Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation
BO Evert, J Araujo, AM Vieira-Saecker, RAI de Vos, S Harendza, ...
Journal of Neuroscience 26 (44), 11474-11486, 2006
Structural and functional analysis of ataxin‐2 and ataxin‐3
M Albrecht, M Golatta, U Wüllner, T Lengauer
European journal of biochemistry 271 (15), 3155-3170, 2004
Bright light therapy in Parkinson's disease: a pilot study
S Paus, T Schmitz‐Hübsch, U Wüllner, A Vogel, T Klockgether, M Abele
Movement disorders: official journal of the Movement Disorder Society 22 (10 …, 2007
The system can't perform the operation now. Try again later.
Articles 1–20